BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

More documents

Recommendations

Info

Slater JE, Pastor RW. The determination of equivalent doses of standardized allergen vaccines. J Allergy Clin Immunol 2000; 105(3):468474. Smith D, InskipPaulk E. Adolescent infectious disease challenges. Adolesc Med 2000 Jun;11(2):21124. Smith KJ, Roberts MS. Cost effectiveness of vaccination strategies in adults without a history of chickenpox [see comments]. Am J Med 2000 Jun 15;108(9):7239. Smith KJ, Roberts MS. Cost effectiveness of vaccination strategies in adults without a history of chickenpox [see comments]. Am J Med 2000 Jun 15;108(9):7239. Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 2000 Jan;23(1):95108. Sohn YM, Rho HO, Park MS, Park JH, Choi BY, Ki M et al. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea. Yonsei Med J 2000; 41(1):3439. Sohn YM. Japanese encephalitis immunization in South Korea: past, present, and future. Emerg.Infect.Dis. 2000;1724. SomodevillaTorres MJ, Hillyard NC, Morton H, Alewood D, Halliday JA, Alewood PF et al. Preparation and characterization of polyclonal antibodies against human chaperonin 10. Cell Stress Chaperones 2000; 5(1):1420. Sonnenberg P, Silber E, Ho KC, Koornhof HJ. Meningococcal disease in South African goldminesepidemiology and strategies for control. S Afr Med J 2000 May;90(5):5137. Sonnenberg P, Silber E, Ho KC, Koornhof HJ. Meningococcal disease in South African goldminesepidemiology and strategies for control. S Afr Med J 2000 May;90(5):5137. Sood SK. Immunization for children traveling abroad. Pediatr Clin North Am 2000; 47(2):43548, viii. Soong W, Schultz JC, Patera AC, Sommer MH, Cohen JI. Infection of human T lymphocytes with varicellazoster virus: an analysis with viral mutants and clinical isolates. J.Virol. 2000;186470. SoRelle R. Influenza vaccine shortages threaten those with chronic diseases [news]. Circulation 2000 Aug 22;102(8):E90145. Soubeyrand B, Boisnard F, Bruel M, Debois H, Delattre D, Gauthier A, Soum S, Thebault C. Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (19891998). Presse Med 2000 Apr 15;29(14):77580. Squires, S. G. and Pelletier, L. Publiclyfunded influenza and pneumococcal immunization programs in Canada: a progress report. Can Commun Dis Rep 2000 Sep 1;26(17):1418 Stange, K. C., Flocke, S. A., Goodwin, M. A., Kelly, R. B., and Zyzanski, S. J. Direct observation of rates of preventive service delivery in community family practice. Prev Med 2000 Aug;31(2 Pt 1):16776 Starr M. A rash of exanthems. How they affect children and pregnant women. Aust Fam Physician 2000 Jul;29(7):6313, 6367. Statement on alternate adolescent schedule for hepatitis B vaccine (ACS5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jul 1;26:1920. Statement on alternate adolescent schedule for hepatitis B vaccine (ACS5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jul 1;26:1920. Statement on immunization for Lyme disease (ACS3). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jul 1;26:1 Statement on influenza vaccination for the 20002001 season. An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jun 1;26:116. Stenzel M. Hepatitis B: the only vaccinepreventable bloodborne pathogen. Med Health R I 2000 Jul;83(7):2014. Stille, C. J. and ChristisonLagay, J. Determining immunization rates for innercity infants: statewide registry data vs medical record review. Am J Public Health 2000 Oct;90(10):16135 Stojanov, S., Liese, J. G., Bendjenana, H., Harzer, E., Barrand, M., Jow, S., Dupuy, M., and Belohradsky, B. H. Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study Group. Pediatr Infect Dis J 2000 Jun;19(6):51621 Stone PW, Teutsch S, Chapman RH, Bell C, Goldie SJ, Neumann PJ. Costutility analyses of clinical preventive services: published ratios, 19761997. Am J Prev Med 2000 Jul;19(1):1523. Stone PW, Teutsch S, Chapman RH, Bell C, Goldie SJ, Neumann PJ. Costutility analyses of clinical preventive services: published ratios, 19761997. Am J Prev Med 2000 Jul;19(1):1523. Stone S. Pneumococcal vaccine and the elderly [letter]. Lancet 2000;5789. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000 Aug;55 Suppl 1:S210. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000 Aug;55 Suppl 1:S210. Stroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, Santonastasi F, Marzolini A, Ciccozzi M, Moiraghi A. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol 2000 Dec;33(6):9805 Subbarao K. As good as the real thing [editorial; comment]. J.Pediatr. 2000;13941. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Maki M, Suzuki H, Ojika K, Ueda R. Hepatitis B virus infection among residents of a nursing home for the elderly: seroepidemiological study and molecular evolutionary analysis. J Med Virol 2000 Dec;62(4):45662 Sunbul, M., Leblebicioglu, H., Esen, S., Eroglu, C., and Barut, S. Response to hepatitis B vaccine in HBsAg/antiHBs negative and antiHBc positive subjects. Scand J Infect Dis 2000;32(3):3156 Supplementary statement on hepatitis A vaccine (ACS4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 2000 Jul 1;26:128. Sutter RW, Hardy IR, Kozlova IA, Tchoudnaia LM, Gluskevich TG, Marievsky V et al. Immunogenicity of tetanusdiphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union. J Infect Dis 2000; 181 Suppl 1:S197S202. Sutter RW, Prevots DR, Cochi SL. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States. Pediatr Clin North Am 2000; 47(2):287308. Sutter RW, Suleiman AJ, Malankar P, AlKhusaiby S, Mehta F, Clements GB, Pallansch MA, Robertson SE. Trial of a supplemental dose of four poliovirus vaccines [see comments]. N Engl J Med 2000 Sep 14;343(11):76773. Swanson ER, Fosnocht DE. Anthrax threats: a report of two incidents from Salt Lake City. J Emerg Med 2000; 18(2):229232. Szilagyi PG, Holl JL, Rodewald LE, Shone LP, Zwanziger J, Mukamel DB, Trafton S, Dick AW, Raubertas RF. Evaluation of children's health insurance: from New York State's CHild Health Plus to SCHIP. Pediatrics 2000;68791. Szilagyi, P. G., Bordley, C., Vann, J. C., Chelminski, A., Kraus, R. M., Margolis, P. A., and Rodewald, L. E. Effect of patient reminder/recall interventions on immunization rates: A review. JAMA 2000 Oct 11;284(14):18207 Takahashi H, Pool V, Tsai1 TF, Chen RT. Adverse events after Japanese encephalitis vaccination: review of postmarketing surveillance data from Japan and the United States. The Working Group. Vaccine 2000 Jul 1;18(26):29639. Takahashi H, Pool V, Tsai1 TF, Chen RT. Adverse events after Japanese encephalitis vaccination: review of postmarketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 2000 Jul 1;18(26):29639. Takahashi M. Development of a live varicella vaccinepast and future. Jpn J Infect Dis 2000 Apr;53(2):4755. Takayama N, Takayama M, Takita J. Herpes zoster in healthy children immunized with varicella vaccine. Pediatr.Infect.Dis.J. 2000;16970. Tarkowski A. Preventing staphylococcal disease by disarming the immune responses to infection. Arch Immunol Ther Exp (Warsz) 2000; 48(1):2126. Tatochenko V, Mitjushin IL. Contraindications to vaccination in the Russian Federation. J Infect Dis 2000; 181 Suppl 1:S228S231. Taylor A, Fisk NM, Glover V. Mode of delivery and subsequent stress response [letter]. Lancet 2000;120.
Taylor JA, Newman RD. Parental attitudes toward varicella vaccination. The Puget Sound Pediatric Research Network. Arch.Pediatr.Adolesc.Med. 2000;302 6. TaylorRobinson, A. W.; Smith, E. C. Naturally acquired versus vaccineinduced immunity to malariaa dual role for TGFbeta and IL12? [letter]. Parasitol Today 2000 Terada K, Niizuma T, Kataoka N, Niitani Y. Testing for rubellaspecific IgG antibody in urine. Pediatr.Infect.Dis.J. 2000;1048. Terkeltaub RA. Lyme disease 2000. Emerging zoonoses complicate patient workup and treatment. Geriatrics 2000 Jul;55(7):345, 3940, 434 passim. Termorshuizen F, DorigoZetsma JW, de Melker HE, van den Hof S, ConynVan Spaendonck MA. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a populationbased survey. Epidemiol Infect 2000 Jun;124(3):45966. Thanassi WT, Schoen RT. The Lyme disease vaccine: conception, development, and implementation. Ann Intern Med 2000; 132(8):661668. Theiler M, Smith HH. The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787800 (1937) [classical article]. Rev.Med.Virol. 2000;616. Thisyakorn U, Pancharoen C, Ruxrungtham K, Ubolyam S, Khawplod P, Tantawichien T, Phanuphak P, Wilde H. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1. Clin.Infect.Dis. 2000;218. Thoelen, S. An overview on a novel adjuvanted prophylactic hepatitis B vaccine. Acta Gastroenterol Belg 2000 AprJun;63(2):1856 Thomas PF, McIntyre PB, Jalaludin BB. Survey of pertussis morbidity in adults in western Sydney [see comments]. Med J Aust 2000 Jul 17;173(2):746. Thomas RE. Preparing patients to travel abroad safely. Part 1: Taking a travel history and identifying special risks. Can.Fam.Physician 2000;1328. Thomson J, Pirkis J, Dunt D. Local registerreminder systems for immunisation in general practice [letter]. Aust Fam Physician 2000; 29(1):1617. Thrower, D. The MMR question [letter]. Lancet 2000 Jul 8;356(9224):161. Tischer A, Gerike E. Immune response after primary and revaccination with different combined vaccines against measles, mumps, rubella. Vaccine 2000;138292. Tollman SM, Zwi AB. Health system reform and the role of field sites based upon demographic and health surveillance. Bull.World Health Organ 2000;125 34. Toussirot E, Lohse A, Wendling D, Mougin C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum. 2000 Sep;43(9):213940. Toussirot, E., Lohse, A., Wendling, D., and Mougin, C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum 2000 Sep;43(9):213940 Touze E, Gout O, VerdierTaillefer MH, LyonCaen O, Alperovitch A. The first episode of central nervous system demyelinization and hepatitis B virus vaccination. Rev Neurol (Paris) 2000 Mar;156(3):2426. Trevejo RT. Rabies preexposure vaccination among veterinarians and atrisk staff. J Am Vet Med Assoc 2000 Dec 1;217(11):164750 Trubatch BN, Fisher DG, Cagle HH, Fenaughty AM. Vaccination strategies for targeted and difficulttoaccess groups :letter. Am.J.Public Health 2000;447. Trujillo C. Meningococcal disease in healthcare workers. Vaccine is available in Latin America [letter]. BMJ 2000;2479. Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 1315 October 1998. Vaccine 2000 May 26;18 Suppl 2:125. Tsai, C. H., Chiu, H. H., and Abe, T. Epidemiologic features of rotavirus infection in Taiwan: a review. Pediatr Int 2000 Aug;42(4):4114 Tschantz, K. and Foley, L. A. Lifesaving opportunities missed: the challenge of vaccinating older Americans for pneumococcal diseases and influenza Issue.Brief.(Public Policy Inst.(Am.Assoc.Retired.Pers.)). 2000, IB45): 19. Tsu V, Tyshchenko DK. Casecontrol evaluation of an adult diphtheria immunization program in Ukraine. J Infect Dis 2000; 181 Suppl 1:S188S192. Tsuru T, Mizuguchi M, Ohkubo Y, Itonaga N, Momoi MY. Acute disseminated encephalomyelitis after live rubella vaccination. Brain Dev 2000 Jun;22(4):25961. Tun KM, Win H, Oo AK, Myint SS, Hla SK, Naing H. Tuberculin conversion after BCG vaccination: comparison by gestation and by age at immunization in Myanmar. Trans R Soc Trop Med Hyg 2000 Mar2000 Apr 30;94(2):21920. Turner JC. Meningococcal vaccine for college freshmen [editorial]. Am Fam Physician 2000 Aug 1;62(3):5012, 505. Umble KE, Cervero RM, Yang B, Atkinson WL. Effects of traditional classroom and distance continuing education: a theorydriven evaluation of a vaccinepreventable diseases course. Am J Public Health 2000 Aug;90(8):121824. Update: expanded availability of thimerosal preservativefree hepatitis B vaccine. MMWR Morb Mortal Wkly Rep 2000 Jul 21;49(28):642, 651. Ushijima, H. Rotavirus infection in Asia. Pediatr Int 2000 Aug;42(4):3924 Usmanov I, Favorov MO, Chorba TL. Universal immunization: the diphtheria control strategy of choice in the Republic of Tajikistan, 19931997. J Infect Dis 2000; 181 Suppl 1:S86S93. Usonis V, Bakasenas V, Morkunas B, Valentelis R, Ching P, Kreysler J. Diphtheria in Lithuania, 19861996. J Infect Dis 2000; 181 Suppl 1:S55S59. Vafai A, F<strong>org</strong>hani B, Kilpatrick D, Ling J, Shankar V. Stability of a varicellazoster virus glycoprotein E epitope. Arch Virol 2000; 145(1):8597. Van Der Most RG, MuraliKrishna K, Ahmed R, Strauss JH. Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virusspecific CD8 Tcell response. J Virol 2000 Sep;74(17):8094101. Vellinga A, Van Damme P, Joossens E, Goossens H. Response to diphtheria booster vaccination in healthy adults: vaccine trial. BMJ 2000;217. Viallard JF, Boiron JM, Parrens M, Moreau JF, Ranchin V, Reiffers J, Leng B, Pellegrin JL. Severe pancytopenia triggered by recombinant hepatitis B vaccine. Br J Haematol 2000 Jul;110(1):2303. Villeneuve, E., Vincelette, J., and Villeneuve, J. P. Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation. Can J Gastroenterol 2000 JulAug;14 Suppl B:59B62B Vinson DR. Immunisation does not rule out tetanus [letter]. BMJ 2000;383. Vitek CR, Bogatyreva EY, Wharton M. Diphtheria surveillance and control in the Former Soviet Union and the Newly Independent States. J Infect Dis 2000; 181 Suppl 1:S23S26. Vitek CR, Velibekov AS. Epidemic diphtheria in the 1990s: Azerbaijan. J Infect Dis 2000; 181 Suppl 1:S73S79. Vogel FR. Improving vaccine performance with adjuvants. Clin Infect Dis 2000 Jun;30 Suppl 3:S26670. Vold PP, Owens DK. Costeffectiveness of the pneumococcal vaccine in the United States Navy and Marine Corps. Clin.Infect.Dis. 2000;15764. Von der Hardt K, Jungert J, Beck JD, Heininger U. Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescentsa retrospective analysis. Vaccine 2000 Jul 1;18(26):29993004. Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 2000 Dec 8;19(910):102637 Vuotto ML, Ielpo MT, Liguori G, Benedetto RD, Moscatiello V, Maselli R. Activation of peripheral phagocytes in BCGvaccinated subjects. Luminescence 2000 May2000 Jun 30;15(3):1537. Wade CF. Keeping Lyme disease at bay. An integrated approach to prevention. Am J Nurs 2000 Jul;100(7):2631; quiz 32. Walt G, Buse K. Partnership and fragmentation in international health: threat or opportunity? [editorial]. Trop Med Int Health 2000 Jul;5(7):46771. Walter R, Hartmann K, Pool V, Gargiullo P, Kuhn M. Reactivation of herpes virus infections by vaccination: evidence or coincidence?, Schweiz Med Wochenschr. 2000 Nov 4;130(44):16858. Wangoo A, Brown IN, Marshall BG, Cook HT, Young DB, Shaw RJ. Bacille CalmetteGuerin (BCG)associated inflammation and fibrosis: modulation by recombinant BCG expressing interferongamma (IFNgamma). Clin.Exp.Immunol. 2000;928. Waters AP, Sauerwein R, Arnot D. Malaria vaccine researchsetting the record straight [letter]. Nat.Med. 2000;234. Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, Orlin S, Levenson R. Postexposure effectiveness of varicella vaccine. Pediatrics 2000;848. Weijer, C. The future of research into rotavirus vaccine [editorial] BMJ 2000 Sep 2;321(7260):5256
Page 1 and 2: BIBLIOGRAFIA SUI DANNI DA VACCINI A
Page 3 and 4: Alter HJ, Scanlon RT, Schechter GP.
Page 5 and 6: Cherry, JD, et al. A Clinical and S
Page 7 and 8: Kazarian EL, Gager WE. Optic neurit
Page 9 and 10: Coplan J. Seizures following immuni
Page 11 and 12: Ipp MM, Gold R, Greenberg S, Goldba
Page 13 and 14: Int J Ped Oto, Feb 1998, 43(1):73
Page 15 and 16: Mashikian MV, Stollerman GH. Vaccin
Page 17 and 18: Wu T, Wang SL, Xiang YZ. Study on t
Page 19 and 20: Prevots DR, Ciofi degli Atti ML, Sa
Page 21 and 22: Del Giudice G, Pizza M, Rappuoli R.
Page 23 and 24: Huber S, Kappos L, Fuhr P, Wetzel S
Page 25 and 26: Ngui SL, Hallet R, Teo CG. Natural
Page 27 and 28: Thomson J, Hilditch A, Pirkis J, Du
Page 29 and 30: Belloni C, Pistorio A, Tinelli C, K
Page 31 and 32: DanielRibeiro CT. Is there a role
Page 33 and 34: Gallup, R. The MMR question [letter
Page 35 and 36: Hull BP, McIntyre PB. A reevaluat
Page 37 and 38: Lieu TA, Ray GT, Black SB, Butler J
Page 39 and 40: Mulholland K. Evaluation of vaccine
Page 41: Rudolph, K. M., Parkinson, A. J., R
Page 45 and 46: Bonaccorsi G, Papini D, Bonanni P,
Page 47 and 48: Hanna, J. N., Young, D. M., Brookes
Page 49 and 50: Mortimer, E. A. Jr, Ball, R., Ball,
Page 51 and 52: Taranger, J., Trollfors, B., Bergfo
Page 53 and 54: Christensen, L. S., Scholler, S., S
Page 55 and 56: Khanal, P. Nepal's Childhood Mortal
Page 57 and 58: Poland GA, Jacobson RM, Vierkant RA
Page 59 and 60: Vyse, A. J., Gay, N. J., White, J.
Page 61 and 62: Brodkin, H. Economic Analysis of In
Page 63 and 64: Freed, G. L., Davis, M. M., and Cla
Page 65 and 66: Karlsen, T. H.; Sommerfelt, H.; Klo
Page 67 and 68: NascimentoCarvalho, C. M.; Moreno
Page 69 and 70: Skegg, D. C. Autism and MeaslesMu
Page 71 and 72: Wharton, M., Strikas, R. A., Harpaz
Page 73 and 74: Boyce, T. G.; Weaver, A. L.; St Sau
Page 75 and 76: D'Heilly, S. J.; Nichol, K. L. Work
Page 77 and 78: Guy, B.; Chanthavanich, P.; Gimenez
Page 79 and 80: Koca, R.; Altinyazar, H. C.; Numano
Page 81 and 82: Modlin, J. F. Poliomyelitis in the
Page 83 and 84: Roost, H. P.; Gassner, M.; Grize, L
Page 85 and 86: Vazquez, M.; LaRussa, P. S.; Gersho
Page 87 and 88: Beaujean, D. J.; Verweij, M. F.; va
Page 89 and 90: Desjeux, G.; GaloisyGuibal, L.; C
Page 91 and 92: Gust, D.; Brown, C.; Sheedy, K.; Hi
Page 93 and 94:
Koch, D.; Thompson, L.; Swart, B. L
Page 95 and 96:
Newport, M. J.; Goetghebuer, T.; Ma
Page 97 and 98:
Satcher, D. Adult Immunization Disp
Page 99 and 100:
Timmermans, D. R.; Henneman, L.; Hi
Page 101 and 102:
Aaby, P.; Jensen, H.; Walraven, G.
Page 103 and 104:
Carrat, F.; Lavenu, A.; Cauchemez,
Page 105 and 106:
Emanuel, E. J.; Wertheimer, A. Publ
Page 107 and 108:
Halperin, S. A.; Sweet, L.; Baxenda
Page 109 and 110:
Klote, M. M.; Engler, R. J.; Martin
Page 111 and 112:
Mitka, M. Age Range Widens for Pert
Page 113 and 114:
Pool, V.; Iskander, J. Safety of In
Page 115 and 116:
Skowronski, D. M.; Woolcott, J. C.;
Page 117 and 118:
Vu, D. M.; Kelly, D.; Heath, P. T.;
Page 119 and 120:
Approved: New Requirement Allowing
Page 121 and 122:
Caldwell, S. J.; Hayney, M. S. Prop
Page 123 and 124:
Dempsey, A. F. Vaccination Against
Page 125 and 126:
Galvani, A. P.; Reluga, T. C.; Chap
Page 127 and 128:
Influenza Vaccination Coverage Amon
Page 129 and 130:
Lawrence, S. J.; Lottenbach, K. R.;
Page 131 and 132:
Monath, T. P. Yellow Fever As an En
Page 133 and 134:
Patrick, D. Prevention Strategies:
Page 135 and 136:
Scheiblhofer, S.; Weiss, R.; Thalha
Page 137 and 138:
Takada, T.; Yamashita, T.; Sato, M.
Page 139 and 140:
Winston, C. A.; Mims, A. D.; Leathe
Page 141 and 142:
Bechtol, Z. Launching a Community
Page 143 and 144:
Chumakov, K.; Ehrenfeld, E. Vaccine
Page 145 and 146:
Dylag, A. M.; Shah, S. I. Administr
Page 147 and 148:
GomezdeLeon, P.; DiazGarcia,
Page 149 and 150:
Jackson, L. A.; Starkovich, P.; Dun
Page 151 and 152:
Kusuhara, K.; Ohga, S.; Hoshina, T.
Page 153 and 154:
Madjid, M. Acute Infections, Vaccin
Page 155 and 156:
Naghipour, M.; Nakagomi, T.; Nakago
Page 157 and 158:
Pool, R.; Mushi, A.; Armstrong, Sch
Page 159 and 160:
Savidan, E.; Chevat, C.; Marsh, G.
Page 161 and 162:
Strauman, T. J.; Coe, C. L.; McCrud
Page 163 and 164:
Vien, N. C.; Feroldi, E.; Lang, J.
Page 165 and 166:
Akmatov, M. K.; Mikolajczyk, R. T.;
Page 167 and 168:
Braillon, A. A New French Paradox:
Page 169 and 170:
Daley, M. F.; Curtis, C. R.; Pyrzan
Page 171 and 172:
Flu Campaign Receives Excellence Aw
Page 173 and 174:
Holvast, A.; van, Assen S.; de, Haa
Page 175 and 176:
Kisakye, A.; Makumbi, I.; Nansera,
Page 177 and 178:
Makidon, P. E.; Nigavekar, S. S.; B
Page 179 and 180:
Niu, M.; Ball, R. Adverse Events Af
Page 181 and 182:
Primus, L. Improving Influenza Vacc
Page 183 and 184:
Schwartz, B.; Orenstein, W. A. Prio
Page 185 and 186:
Tharmaphornpilas, P.; Yoocharean, P
Page 187 and 188:
Weiskopf, D.; Weinberger, B.; Grube
show all

BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Create successful ePaper yourself

Delete template?

Save as template?